Multiproject–multicenter evaluation of automatic brain tumor classification by magnetic resonance spectroscopy JM García-Gómez, J Luts, M Julià-Sapé, P Krooshof, S Tortajada, ... Magnetic Resonance Materials in Physics, Biology and Medicine 22, 5-18, 2009 | 171 | 2009 |
Bioinspired theranostic coordination polymer nanoparticles for intranasal dopamine replacement in Parkinson’s disease J García-Pardo, F Novio, F Nador, I Cavaliere, S Suárez-García, ... ACS nano 15 (5), 8592-8609, 2021 | 73 | 2021 |
Prospective diagnostic performance evaluation of single‐voxel 1H MRS for typing and grading of brain tumours M Julià‐Sapé, I Coronel, C Majós, AP Candiota, M Serrallonga, M Cos, ... NMR in biomedicine 25 (4), 661-673, 2012 | 72 | 2012 |
Dual T1/T2 Nanoscale Coordination Polymers as Novel Contrast Agents for MRI: A Preclinical Study for Brain Tumor S Suárez-García, N Arias-Ramos, C Frias, AP Candiota, C Arús, ... ACS applied materials & interfaces 10 (45), 38819-38832, 2018 | 65 | 2018 |
DCE@ urLAB: a dynamic contrast-enhanced MRI pharmacokinetic analysis tool for preclinical data JE Ortuño, MJ Ledesma-Carbayo, RV Simões, AP Candiota, C Arús, ... BMC bioinformatics 14, 1-17, 2013 | 56 | 2013 |
Targeting protein kinase CK2: evaluating CX-4945 potential for GL261 glioblastoma therapy in immunocompetent mice L Ferrer-Font, L Villamañan, N Arias-Ramos, J Vilardell, M Plana, ... Pharmaceuticals 10 (1), 24, 2017 | 49 | 2017 |
In vivo proton magnetic resonance spectroscopy of intraventricular tumours of the brain C Majós, C Aguilera, M Cos, À Camins, AP Candiota, T Delgado-Goñi, ... European Radiology 19, 2049-2059, 2009 | 45 | 2009 |
MRSI‐based molecular imaging of therapy response to temozolomide in preclinical glioblastoma using source analysis T Delgado‐Goñi, S Ortega‐Martorell, M Ciezka, I Olier, AP Candiota, ... NMR in Biomedicine 29 (6), 732-743, 2016 | 35 | 2016 |
Non-invasive grading of astrocytic tumours from the relative contents of myo-inositol and glycine measured by in vivo MRS AP Candiota, C Majós, M Julià-Sapé Journal of the Belgian Society of Radiology 94 (6), 319-329, 2011 | 35 | 2011 |
Molecular imaging coupled to pattern recognition distinguishes response to temozolomide in preclinical glioblastoma T Delgado‐Goñi, M Julià‐Sapé, AP Candiota, M Pumarola, C Arús NMR in Biomedicine 27 (11), 1333-1345, 2014 | 34 | 2014 |
Metronomic treatment in immunocompetent preclinical GL261 glioblastoma: effects of cyclophosphamide and temozolomide L Ferrer‐Font, N Arias‐Ramos, S Lope‐Piedrafita, M Julià‐Sapé, ... NMR in Biomedicine 30 (9), e3748, 2017 | 32 | 2017 |
Efficient γ-amino-proline-derived cell penetrating peptide–superparamagnetic iron oxide nanoparticle conjugates via aniline-catalyzed oxime chemistry as bimodal imaging nanoagents S Cavalli, D Carbajo, M Acosta, S Lope-Piedrafita, AP Candiota, C Arus, ... Chemical Communications 48 (43), 5322-5324, 2012 | 32 | 2012 |
Metabolomics of therapy response in preclinical glioblastoma: A multi-slice MRSI-based volumetric analysis for noninvasive assessment of temozolomide treatment N Arias-Ramos, L Ferrer-Font, S Lope-Piedrafita, V Mocioiu, M Julià-Sapé, ... Metabolites 7 (2), 20, 2017 | 28 | 2017 |
A new ex vivo method to evaluate the performance of candidate MRI contrast agents: a proof-of-concept study AP Candiota, M Acosta, RV Simões, T Delgado-Goñi, S Lope-Piedrafita, ... Journal of nanobiotechnology 12 (1), 12, 2014 | 26 | 2014 |
Improving the classification of brain tumors in mice with perturbation enhanced (PE)-MRSI RV Simões, S Ortega-Martorell, T Delgado-Goñi, YL Fur, M Pumarola, ... Integrative Biology 4 (2), 183-191, 2012 | 26 | 2012 |
In Vivo and Ex Vivo Magnetic Resonance Spectroscopy of the Infarct and the Subventricular Zone in Experimental Stroke E Jiménez-Xarrié, M Davila, S Gil-Perotín, A Jurado-Rodríguez, ... Journal of Cerebral Blood Flow & Metabolism 35 (5), 828-834, 2015 | 25 | 2015 |
Metal-Free Radical Dendrimers as MRI Contrast Agents for Glioblastoma Diagnosis: Ex Vivo and In Vivo Approaches S Zhang, V Lloveras, S Lope-Piedrafita, P Calero-Pérez, S Wu, ... Biomacromolecules 23 (7), 2767-2777, 2022 | 24 | 2022 |
Anti‐tumour immune response in GL261 glioblastoma generated by Temozolomide Immune‐Enhancing Metronomic Schedule monitored with MRSI‐based nosological images S Wu, P Calero‐Pérez, L Villamañan, N Arias‐Ramos, M Pumarola, ... NMR in Biomedicine 33 (4), e4229, 2020 | 23 | 2020 |
Cancer metabolism in a snapshot: MRS (I) M Julià‐Sapé, AP Candiota, C Arús NMR in Biomedicine 32 (10), e4054, 2019 | 23 | 2019 |
Strategies for annotation and curation of translational databases: the eTUMOUR project M Julià-Sapé, M Lurgi, M Mier, F Estanyol, X Rafael, AP Candiota, ... Database 2012, bas035, 2012 | 23 | 2012 |